Exploring Extended Adjuvant Endocrine Therapy for HR+ Breast Cancer

Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone rec...Подробнее

Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapyПодробнее

Exploring Adjuvant Endocrine Therapy in the Breast Cancer SettingПодробнее

Challenges With Patient Selection for Extended Adjuvant Endocrine Therapy in Breast CancerПодробнее

Adjuvant endocrine therapy for breast cancer: optimal durations and regimensПодробнее

Transgender men have breast cancer#shorts #subscribe #movie #tvshowПодробнее

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

Breast Cancer: Extended Adjuvant Endocrine TherapyПодробнее

Exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancerПодробнее

Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

EXTENDED ADJUVANT HORMONAL THERAPY IN EARLY BREAST CANCERПодробнее

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice GuidelinesПодробнее

Dr. Burstein on Adjuvant Endocrine Therapy for ER+ Breast CancerПодробнее

Exploring extended adjuvant chemotherapy for luminal cancersПодробнее

Exploring Neoadjuvant Therapy for Breast Cancer: What You Need to KnowПодробнее

Dr. Graff on Extended Adjuvant Therapy in Early-Stage HR+ Breast CancerПодробнее

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast CancerПодробнее

Adjuvant treatment for high risk HR+ breast cancer | ESMO 2023 Breast Cancer HighlightsПодробнее

Optimizing adjuvant endocrine therapy for early Breast CancerПодробнее